In our recent report on Medical Devices  Edwards Life Sciences was a top pick of Kristen M. Stewart,Vice President and Senior Analyst , Credit Suisse  and here is why ;

Ms. Stewart: One company that I like at the present time is Ed­wards Lifesciences. It’s more of a mid-cap cardiovascular company. They are developing a new product, it’s called the transcatheter heart valve. They are selling it in Eu­rope and are in clinical trials in the United States. It’s really one of the largest areas of new innovation. I think transcatheter heart valves can certainly be the next big thing in medical devices. It could be a multibillion-dollar market opportunity for a company of that size; that is very significant. These valves can really drive accelerating top- and bottom-line growth.

Make sure to follow us on TWITTER

This entry was posted on Monday, September 28th, 2009 at 3:01 pm and is filed under Healthcare Stocks. You can follow any responses to this entry through the RSS 2.0 feed.